What to Expect in Month 1 Appetite changes: Noticeable suppression begins week 3-4 for most Mild nausea: 40% experience some nausea, usually mild Injection site reactions: Redness, itching, or mild pain at injection site (14% of patients) Fatigue: Some patients report low energy as body adjusts Bowel changes: Either constipation or looser stools as medication affects gut motility 4 Essential Strategies for Month 1 1
Browse all Peptides & GLP-1 education GLP-1 receptor agonists work while they are in your system and their effects fade once they leave it
Having everything ready prevents rushing or distraction during the actual injection
These medications have genuinely transformed how we manage type-2 diabetes and weight loss, and many patients are seeing remarkable results
Anxiety on tirzepatide and muscle pain with tirzepatide have also been reported, though these are less common
While initial animal studies demonstrated a potential biological mechanism for increased risk of PDAC, this has not been observed in humans to date
